Reaction

Which drugs are most reported with Fear of injection?

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 6,888 reports · 114 co-occurring drugs

As of the last recalculation, Fear Of Injection appears in 6,888 FAERS reports alongside 114 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 27.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dimenhydrinate	95	27.3	27.5
Febuxostat Tablets 40 Mg	78	23.4	23.6
Febuxostat Tablets 80 Mg	78	23.4	23.6
Febuxostat	79	14.4	14.5
Evolocumab	626	12.7	12.8
Colchicine	86	10.0	10.0
Adalimumab-Adaz	169	9.9	9.9
Bendamustine Hydrochloride	38	9.6	9.7
Abaloparatide	91	9.5	9.5
Risedronate Sodium	91	9.0	9.0
Sulfasalazine	222	8.8	8.8
Fremanezumab-Vfrm	33	8.7	8.7
Asfotase Alfa	28	8.5	8.5
Ibuprofen And Diphenhydramine Citrate	62	8.1	8.1
Dupilumab	1,093	8.0	8.0
Galcanezumab-Gnlm	80	7.8	7.8
Somatropin	183	7.7	7.7
Adalimumab-Fkjp	115	7.6	7.6
Dexlansoprazole	102	7.5	7.5
Adalimumab-Aaty	112	7.3	7.3
Hydroxychloroquine Sulfate	209	7.1	7.1
Diphenhydramine Hydrochloride Capsule, Liquid Filled	46	6.5	6.6
Infliximab-Dyyb	61	6.4	6.4
Human Immunoglobulin G	43	6.3	6.3
Etanercept	1,069	6.2	6.2
Glatiramer Acetate	119	6.1	6.1
Ciclesonide	27	6.0	6.0
Leflunomide	201	5.9	6.0
Certolizumab Pegol	220	5.8	5.8
Adalimumab	1,153	5.7	5.7
Naproxen	142	5.6	5.6
Erenumab-Aooe	99	5.5	5.5
Interferon Beta-1A	331	5.4	5.4
Oral Semaglutide	126	5.3	5.3
Hydroxychloroquine	113	4.6	4.6
Tofacitinib	272	4.6	4.6
Golimumab	123	4.4	4.4
Methotrexate Sodium	647	4.3	4.3
Secukinumab	212	4.1	4.1
Anakinra	22	4.0	4.0
Methotrexate	520	4.0	4.0
Aflibercept	39	3.8	3.8
Desoximetasone	23	3.7	3.7
Ustekinumab	121	3.6	3.6
Azathioprine	104	3.6	3.6
Ofatumumab	39	3.6	3.6
Tocilizumab	132	3.5	3.5
Celecoxib	145	3.4	3.4
Omalizumab	94	3.4	3.4
Diphenhydramine Hydrochloride	180	3.3	3.3
Naproxen Sodium	153	3.3	3.3
Emicizumab	13	3.2	3.2
Teduglutide	14	3.1	3.1
Mesalamine	58	3.1	3.1
Cetirizine Hcl	9	3.0	3.0
Infliximab	210	3.0	3.0
Cyclosporine	107	2.9	2.9
Vedolizumab	81	2.9	2.9
Bimekizumab	20	2.8	2.8
Crisaborole	9	2.8	2.8
Octreotide Acetate	28	2.8	2.8
Folic Acid	216	2.7	2.7
Prednisone	425	2.7	2.7
Hydroxyzine Hydrochloride	11	2.5	2.5
Hydroxyzine Hydrochloride Oral	11	2.5	2.5
Vincristine Sulfate	24	2.5	2.5
Alendronate Sodium Tablet	15	2.4	2.5
Abatacept	108	2.4	2.4
Azelastine	14	2.4	2.4
Diphenhydramine	49	2.4	2.4
Rituximab	160	2.3	2.3
Apremilast	111	2.3	2.3
Methimazole	6	2.3	2.3
Ixekizumab	28	2.3	2.3
Naproxen Sodium Tablet, Coated	10	2.2	2.2
Naproxen Sodium, Coated Tablets	10	2.2	2.2
Naproxen Sodium 220Mg	10	2.2	2.2
Interferon Beta-1B	14	2.2	2.2
Epinephrine	45	2.1	2.1
Peginterferon Beta-1A	9	2.1	2.1
Triamcinolone Acetonide Ointment Usp, 0.05%	16	2.1	2.1
Naltrexone	21	2.1	2.1
Clobetasol Propionate Ointment Usp, 0.05%	7	2.1	2.1
Clobetasol Propionate	7	2.0	2.0
Mupirocin	9	2.0	2.0
Mepolizumab	33	2.0	2.0
Mupirocin Calcium	9	2.0	2.0
Paliperidone Palmitate	21	2.0	2.0
Alirocumab	16	1.9	1.9
Cetirizine Hydrochloride Allergy	19	1.9	1.9
Cetirizine Hydrochloride Tablets	19	1.9	1.9
Adrenalinum	26	1.9	1.9
Oxycodone	112	1.8	1.8
Guselkumab	20	1.7	1.7
Canakinumab	6	1.7	1.7
Triamcinolone Acetonide	16	1.6	1.6
Lanreotide Acetate	4	1.5	1.5
Benralizumab	10	1.5	1.5
Diclofenac Potassium, Film Coated	4	1.4	1.4
Diclofenac Potassium Tablets	4	1.4	1.4
Dulaglutide	42	1.4	1.4
Belimumab	15	1.4	1.4
Risankizumab-Rzaa	38	1.4	1.4
Sarilumab	12	1.4	1.4
Fexofenadine Hydrochloride	9	1.3	1.3
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	16	1.2	1.2
Diclofenac Potassium	4	1.1	1.1
Teriparatide	37	1.0	1.0
Cariprazine	3	1.0	1.0
Rimegepant Sulfate	4	1.0	1.0
Paliperidone	7	0.9	0.9
Pegfilgrastim	22	0.7	0.7
Romosozumab-Aqqg	3	0.7	0.7
Tirzepatide	25	0.5	0.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.